Latest nitrosamines recall spotlighting need to control pharmaceutical impurities
Quality Matters
NOVEMBER 11, 2022
FDA) workshop , my fellow panelist and I addressed the latest developments in the identification and control of nitrosamines in pharmaceutical products. Nitrosamines have represented a significant challenge for industry and regulators for some time. Earlier this year, at a U.S. Food and Drug Administration (U.S.
Let's personalize your content